|
Model Number M0061752620 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Pain (1994)
|
Event Date 03/07/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Report source: study: u0652 double-j registry clinical study.(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|
|
Event Description
|
It was reported to boston scientific corporation that a previously implanted percuflex plus ureteral stent was removed from the left ureter, performed on (b)(6) 2022 as part of the u0652 double-j registry clinical study.On (b)(6) 2022, the percuflex plus ureteral stent was successfully placed for stone management in the left ureter, and the patient was prescribed the discharge medications, acetaminophen (tylenol) and non steroidal anti inflammatory drugs (nsaid)s.No issues were noted with the device.On (b)(6) 2022, the patient had experienced a left flank pain.The patient was given toradol, morphinr, iv fluids, norco, keflex, cipro to treat the pain.During the planned stent removal performed on (b)(6) 2022, the percuflex plus ureteral stent was successfully removed from the patient without any difficulty.There was no new device implanted.On (b)(6) 2022 the event was considered resolved.
|
|
Manufacturer Narrative
|
Block g3: study: u0652 double-j registry clinical study.Block h6: medical problem code e2330 is being used to capture the reportable issue of pain.Block h10: block b5 have been updated based on additional information received october 31, 2022.
|
|
Event Description
|
It was reported to boston scientific corporation that a previously implanted percuflex plus ureteral stent was removed from the left ureter, performed on (b)(6) 2022, as part of the u0652 double-j registry clinical study.On (b)(6) 2022, the percuflex plus ureteral stent was successfully placed for stone management in the left ureter, and the patient was prescribed the discharge medications, acetaminophen (tylenol) and non-steroidal anti-inflammatory drugs (nsaid)s.No issues were noted with the device.On march 11, 2022, the patient had experienced a left flank pain.The patient was given toradol, morphinr, iv fluids, norco, keflex, cipro to treat the pain.During the planned stent removal performed on (b)(6) 2022, the percuflex plus ureteral stent was successfully removed from the patient without any difficulty.There was no new device implanted.On (b)(6) 2022, the event was considered resolved.Additional information received that the onset date was on march 7, 2022, and the procedure outcome was unknown.The event of moderate left-sided flank pain, requiring treatment with medication and hospitalization, and reported to be probably related to the procedure, probably related to the device and not related to stent removal.
|
|
Search Alerts/Recalls
|
|
|